Medical academic societies expressed their support for the Korean government’s decision to suspend manufacturing and sales of metformin with excessive level of impurity found. However, the scholars noted diabetic patients should not stop taking metformin without consulting their doctors.

On May 26, Korean Diabetes Association (KDA) and Korean Endocrine Society (KES) issued a joint statement on the government suspension on manufacturing and sales of metformin upon discovery of N-Nitrosodimethylamine (NDMA) exceeding an acceptable level. The statement first expressed gratitude for the Ministry of Food and Drug Safety’s (MFDS) prompt but proactive action on the metformin products and their safety issue, an